A patient‐ and acquisition‐tailored injection approach for improving consistency of CT enhancement towards a target CT value in coronary CT angiography

Abstract Background Unoptimized coronary CT angiography (CTA) exams typically result in a highly variable arterial enhancement (HUa) across patients. This study aimed at harmonizing arterial enhancement by implementing a patient‐, contrast‐ and kV‐tailored injection protocol. Methods First, the optimal body size metric to predict HUa was identified by retrospectively analysing images of 76 patients, acquired with 70 ml contrast media (G1). Second, using phantom experiments, correction factors for the effect of kV and contrast concentration on HUa were determined. Third, a model was developed, prescribing the optimal contrast dose to be injected to obtain a diagnostically appropriate arterial target enhancement HUtarget. The model was then validated on 278 prospectively collected patients, in two groups with two different HUtarget: 525 HU (207 patients, G2A) and 425 HU (71 patients, G2B). The HUa histograms were compared among groups and to the target enhancement through their mean and standard deviation (SD) at 100 kVp reference level. Also, signal‐to‐noise ratio was obtained and compared among the groups. Results Fat free mass (FFM) showed the highest correlation with HUa (r = 0.69). KVp correction factors ranged from 0.65 at 70 kVp to 1.22 at 140 kVp. The obtained model reduced the group heterogeneity (SD) from 101HU for reference G1 to 75HU (p < 0.001) for G2A and 68HU (p < 0.001) for G2B. The mean HUa of 506HU in G2A was slightly below HUtarget = 525HU (p = 0.01) whereas in G2B, the mean HUa of 414HU was not significantly different from HUtarget = 425HU (p = 0.54). The total iodine dose was lowered from 19.5 g‐I to 17.6 g‐I and 14.2 g‐I from G1 to G2A and G2B, on average. Conclusion A contrast injection model, based on patient's fat free mass and accounting for the contrast agent concentration and the planned CT‐scan tube voltage, harmonized arterial enhancement among patients towards a predefined target enhancement in coronary CTA scanning, without affecting the bolus timing.

[1]  Simon S. Martin,et al.  Evaluation of a Tube Voltage-Tailored Contrast Medium Injection Protocol for Coronary CT Angiography: Results From the Prospective VOLCANIC Study. , 2020, AJR. American journal of roentgenology.

[2]  D. Bluemke,et al.  An Optimized Test Bolus Contrast Injection Protocol for Consistent Coronary Artery Luminal Enhancement for Coronary CT Angiography. , 2020, Academic radiology.

[3]  J. Wildberger,et al.  Personalization of CM Injection Protocols in Coronary Computed Tomographic Angiography (People CT Trial) , 2020, Contrast media & molecular imaging.

[4]  J. de Mey,et al.  Iodine Dose of Administered Contrast Media Affects the Level of Radiation-Induced DNA Damage During Cardiac CT Scans. , 2019, AJR. American journal of roentgenology.

[5]  B. Ghoshhajra,et al.  Advances in cardiac CT contrast injection and acquisition protocols. , 2017, Cardiovascular diagnosis and therapy.

[6]  M. Pearce,et al.  Enhanced radiation dose and DNA damage associated with iodinated contrast media in diagnostic X-ray imaging. , 2017, The British journal of radiology.

[7]  D. Kallmes,et al.  Is Intravenous Administration of Iodixanol Associated with Increased Risk of Acute Kidney Injury, Dialysis, or Mortality? A Propensity Score-adjusted Study. , 2017, Radiology.

[8]  R. Leijenaar,et al.  Contrast Media Administration in Coronary Computed Tomography Angiography – A Systematic Review , 2017, RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren.

[9]  H. Alkadhi,et al.  CT Angiography of the Aorta: Prospective Evaluation of Individualized Low-Volume Contrast Media Protocols. , 2016, Radiology.

[10]  Y. Yamashita,et al.  The Optimal Body Size Index with Which to Determine Iodine Dose for Hepatic Dynamic CT: A Prospective Multicenter Study. , 2016, Radiology.

[11]  Cunxue Pan,et al.  Improving Patient to Patient CT Value Uniformity with an Individualized Contrast Medium Protocol Tailored to Body Weight and Contrast Medium Concentration in Coronary CT Angiography , 2015, PloS one.

[12]  Nico Buls,et al.  Contrast agent and radiation dose reduction in abdominal CT by a combination of low tube voltage and advanced image reconstruction algorithms , 2014, European Radiology.

[13]  Richard Solomon,et al.  Side Effects of Radiographic Contrast Media: Pathogenesis, Risk Factors, and Prevention , 2014, BioMed research international.

[14]  J. Ellis,et al.  Contrast material-induced nephrotoxicity and intravenous low-osmolality iodinated contrast material: risk stratification by using estimated glomerular filtration rate. , 2013, Radiology.

[15]  I. Jovin,et al.  Adverse Reactions to Iodinated Contrast Media , 2013, International Journal of Angiology.

[16]  D. Hough,et al.  Individualization of abdominopelvic CT protocols with lower tube voltage to reduce i.v. contrast dose or radiation dose. , 2013, AJR. American journal of roentgenology.

[17]  M. Kanematsu,et al.  Body size indices to determine iodine mass with contrast-enhanced multi-detector computed tomography of the upper abdomen: does body surface area outperform total body weight or lean body weight? , 2013, European Radiology.

[18]  S. Achenbach,et al.  Which concentration to choose in dual flow cardiac CT?: dual flow cardiac CT. , 2012, European journal of radiology.

[19]  K. Bae,et al.  Intravenous contrast medium administration and scan timing at CT: considerations and approaches. , 2010, Radiology.

[20]  W. Heindel,et al.  Introduction of an individually optimized protocol for the injection of contrast medium for coronary CT angiography , 2009, European Radiology.

[21]  Y. Yamashita,et al.  Effect of contrast injection protocols with dose adjusted to the estimated lean patient body weight on aortic enhancement at CT angiography. , 2009, AJR. American journal of roentgenology.

[22]  Xiangying Du,et al.  64-MDCT coronary angiography: phantom study of effects of vascular attenuation on detection of coronary stenosis. , 2008, AJR. American journal of roentgenology.

[23]  Y. Yamashita,et al.  Contrast Injection Protocols for Coronary Computed Tomography Angiography Using a 64-Detector Scanner: Comparison Between Patient Weight-Adjusted- and Fixed Iodine-Dose Protocols , 2008, Investigative radiology.

[24]  W. Bautz,et al.  Right heart: split-bolus injection of diluted contrast medium for visualization at coronary CT angiography. , 2008, Radiology.

[25]  Pamela K Woodard,et al.  Contrast enhancement in cardiovascular MDCT: effect of body weight, height, body surface area, body mass index, and obesity. , 2008, AJR. American journal of roentgenology.

[26]  S. Duffull,et al.  What is the best size descriptor to use for pharmacokinetic studies in the obese? , 2004, British journal of clinical pharmacology.

[27]  H. Thomsen,et al.  Adverse reactions to iodinated contrast media , 2001, European Radiology.

[28]  B V Howard,et al.  Relations of Stroke Volume and Cardiac Output to Body Composition: The Strong Heart Study , 2001, Circulation.

[29]  Eric D. Nordmoe.  Testing the Significance of Correlations , 1996 .

[30]  R Hume,et al.  Prediction of lean body mass from height and weight , 1966, Journal of clinical pathology.

[31]  B. Hamm,et al.  High-pitch dual-source CT coronary angiography with low volumes of contrast medium , 2013, European Radiology.

[32]  R. Mosteller.  Simplified calculation of body-surface area. , 1987, The New England journal of medicine.

[33]  J. Garrow,et al.  Quetelet's index (W/H2) as a measure of fatness. , 1985, International journal of obesity.